Female Cancer Marker Package 2

Female Cancer Marker Package 2


Alpha-fetoprotein (AFP) is used as a tumor marker to help detect and diagnose cancers of the liver, testicles, and ovaries.

Carcinoembryonic antigen (CEA) is used as a tumor marker. An elevated or rising CEA level indicates cancer progression or recurrence.

CA 19-9 is a tumor marker that is used primarily in the management of pancreatic cancer.

CA 125 test is used to look for early signs of ovarian cancer in women with a very high risk of the disease. 

Human chorionic gonadotropin (HCG or b-HCG) is a hormone normally produced by the placenta during pregnancy. It is also produced by certain cancer cells.

CA15-Cancer antigen 15-3 is a protein produced by a variety of cells, particularly breast cancer cells.

This package includes the following screening:

1. Alpha Fetoprotein

2. Carcinoembryonic Antigen

3. CA 19.9

4. CA 125 (Female)

5. Total HCG

6. CA 15.3

Sample for testing: Blood